Astrazeneca Pharma India Limited, Fundamental analysis

Industry Industry name	Pharmaceuticals
Variance Full Year Net Profit Variance	9
Equity Latest Equity	5
Face Value Latest Face Value	2
Reserves Total Reserve	867.79
Dividend Full Year Dividend %	1800
Sales Turnover Full Year Net Sales	2275.58
Net Profit Full Year Net Profit	191.31
Full Year CPS Full Year Cash Per Share	88
Earning Per Share Full Year Earning Per Share	76.5
Quarter CPS Latest quarter Cash Per Share	0
Latest Quarter Date Latest Quarter Yrc	Sep 1, 2026
Latest Quarter Sales Latest Quarter Net Sales	729.1
Previous EPS Previous earnings per share	0
Book Value Book value	349.1
Networth Full Year Return on Networth	22.82
Price/Book Value Price to Book value	18.032083
Yearly PE ratio Full Year Price to Earning per share	82.3
Yearly PC ratio Full Year Price to Cash Per Share	71.6
Bse value BSE Value in lakhs	11.54
Nse value NSE Value in lakhs	273.64
High 52 week high	9587
Low 52 week low	5660
Price NSE Current market price	6294
CPM Current market price	6295

Market cap BSE / NSE Market Cap	15737.25
Net profit Latest Quarter Net Profit	72.87
Net profit variance Latest Quarter Net Profit variance	25
Result year Trailing latest month	Jun 1, 2026
TTM Sales Trailing Twelve 12 month Net Sales	1484.51
TTM OP Trailing Twelve 12 month Operating Profit	102.63
TTM OPM Trailing Twelve 12 month Operating Profit Margin	6.91
TTM GP Trailing Twelve 12 month Gross Profit	245.49
TTM GPM Trailing Twelve 12 month Gross Profit Margin	10.09
TTM NP Trailing Twelve 12 month Net Profit	128.73
TTM NPV Trailing Twelve 12 month Net Profit Variane	-17.96
TTM EPS Trailing Twelve 12 month EPS	69.39
TTM PE Trailing Twelve 12 month PE	90.72
TTM CPS Trailing Twelve 12 month CPS	0
Month CPS Month Cash Per Share	0
TTM Depreciation Trailing Twelve 12 month Depreciation	20.69
Equity Latest Equity	5
LTP Latest Price (BSE/NSE)	6295
Gross block Latest Gross Block	184.76
Loans Total loans	110.66
Advances Latest Advances for Banks	0
Net profit asset Latest Assets	0
Year OPM Full Year Operating Profit Margin	11.5
Year GPM Full Year Gross Profit Margin	12.6
Quarter OPM Latest quater Operation Profit Margin	13.1

	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
+ Sales	440	480	526	559	612	579	683	729
YOY Sales Growth %	44%	25%	36%	37%	39%	20%	30%	30%
Gross Sales	440	480	526	559	612	579	683	729
+ Expenses	397	400	446	489	567	519	634	648
Material Cost %	28%	45%	27%	19%	54%	-14%	-21%	21%
Raw Material Cost	70	94	9	0	0	0	0	0
Change in Inventory	52	123	132	108	331	-82	-143	150
Manufacturing Cost %	15%	11%	12%	14%	11%	7%	11%	12%
Employee Cost %	14%	14%	12%	11%	15%	8%	12%	9%
Other Cost %	34%	13%	34%	44%	12%	89%	91%	47%
Raw Materials %	16%	20%	2%	0%	0%	0%	0%	0%
Purchase of Finished Goods %	52%	60%	79%	77%	114%	54%	45%	86%
Stock Adjustments %	-12%	-25%	-25%	-19%	-54%	14%	21%	-21%
Other Manufacturing Expenses %	15%	11%	12%	14%	11%	7%	11%	12%
Selling & Administration %	5%	5%	4%	5%	6%	5%	5%	2%
Provisions & Contingencies %	-0%	-0%	0%	0%	0%	1%	0%	0%
Operating Profit	43	81	81	70	45	60	49	81
OPM %	10%	17%	15%	13%	7%	10%	7%	11%
+ Other Income	8	16	11	6	7	6	9	15
Miscellaneous Income	8	16	11	6	7	6	9	15
Exceptional Income	0	0	0	0	1	0	0	0
Interest	0	1	1	1	1	2	2	2
Depreciation	9	18	17	3	4	6	5	5
Profit before tax	42	78	75	73	47	58	51	88
+ Tax %	27%	26%	25%	26%	30%	23%	25%	30%
Current Tax	12	23	22	19	4	14	11	25
Deferred Tax	-1	-3	-3	0	10	-1	2	1
+ Net Profit	31	58	56	54	33	45	38	62
Extraordinary Income / Expense	-34	-6	0	-5	1	-1	0	-15
Exceptional Item	-34	-6	0	-5	1	-1	0	-15
EPS in Rs

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
+ Sales	549	572	728	832	814	806	1,003	1,296	1,716	2,276
Sales Growth %		4%	27%	14%	-2%	-1%	24%	29%	32%	33%
Gross Sales	539	570	728	832	814	806	1,003	1,296	1,716	2,276
Excise Duty	5	1	0	0	0	0	0	0	0	0
+ Expenses	512	526	657	711	678	719	878	1,111	1,559	2,019
Material Cost %	32%	32%	32%	37%	36%	39%	36%	46%	56%	61%
Raw Material Cost	156	232	233	344	292	297	409	628	1,296	1,869
Change in Inventory	18	-51	-1	-39	3	14	-49	-34	-333	-488
Manufacturing Cost %	3%	3%	2%	2%	2%	2%	2%	1%	1%	1%
Employee Cost %	30%	26%	27%	26%	27%	29%	26%	19%	15%	12%
Other Cost %	29%	31%	29%	21%	18%	20%	24%	20%	18%	15%
Raw Materials %	28%	40%	32%	41%	36%	37%	41%	48%	76%	82%
Purchase of Finished Goods %	26%	36%	23%	33%	24%	26%	32%	39%	59%	82%
Stock Adjustments %	-3%	9%	0%	5%	-0%	-2%	5%	3%	19%	21%
Power & Fuel %	1%	1%	1%	1%	1%	1%	1%	0%	0%	0%
Other Manufacturing Expenses %	1%	1%	1%	1%	1%	1%	1%	1%	1%	1%
Selling & Administration %	26%	29%	27%	19%	16%	18%	19%	18%	12%	14%
Miscellaneous Expenses %	2%	2%	2%	2%	2%	2%	5%	2%	6%	2%
Provisions & Contingencies %	0%	0%	0%	0%	0%	0%	0%	0%	0%	1%
Operating Profit	37	46	71	121	135	86	125	184	157	257
OPM %	7%	8%	10%	15%	17%	11%	12%	14%	9%	11%
+ Other Income	14	12	16	13	13	15	26	51	41	28
Miscellaneous Income	14	12	16	13	13	15	26	51	41	30
Exceptional Income	0	0	0	0	0	0	0	16	0	1
Interest	0	0	0	1	1	1	1	1	1	4
Depreciation	16	15	15	19	20	17	16	15	40	29
Profit before tax	36	44	73	114	127	83	134	220	156	252
+ Tax %	44%	41%	25%	37%	27%	26%	26%	26%	26%	26%
Current Tax	9	9	17	32	35	23	38	59	61	59
Deferred Tax	7	9	2	10	-1	-1	-3	-1	-20	5
+ Net Profit	20	26	54	72	93	62	99	162	116	188
Profit Growth %		30%	109%	33%	29%	-34%	61%	63%	-28%	62%
Extraordinary Income / Expense	0	0	0	0	0	0	-40	16	-97	-5
Exceptional Item	0	0	0	0	0	0	-40	16	-97	-5
EPS in Rs

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	5	5	5	5	5	5	5	5	5	5
Reserves	218	242	296	359	451	506	584	707	765	868
+ Borrowings	0	0	0	12	12	9	7	5	36	111
Unsecured Borrowings	0	0	0	12	12	9	7	5	36	111
+ Other Liabilities	193	214	261	330	306	337	389	362	712	1,006
Current Liabilities	194	209	260	328	303	331	382	356	706	995
Provisions	33	40	36	46	43	48	44	50	117	61
Other liability items	2	7	2	5	6	8	9	6	15	38
Total Liabilities	415	461	562	706	775	857	985	1,078	1,518	1,989
+ Fixed Assets	87	75	75	72	81	74	69	67	64	117
Gross Block	103	106	120	133	160	169	179	187	218	185
Accumulated Depreciation	16	30	45	61	79	94	110	120	153	67
CWIP	5	4	7	24	4	2	1	0	0	0
Investments	0	0	0	0	0	0	0	0	0	0
+ Other Assets	324	382	480	611	690	780	915	1,011	1,454	1,872
Inventories	58	113	118	165	160	140	190	228	549	1,027
Trade receivables	43	55	80	83	85	86	108	153	185	214
Cash Equivalents	116	126	173	253	352	448	500	506	537	449
Loans n Advances	79	62	58	59	39	49	59	68	123	116
Other asset items	29	26	51	51	54	56	57	56	61	66
Total Assets	415	461	562	706	775	857	985	1,078	1,518	1,989

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
+ Cash from Operating Activity	38	9	55	87	105	101	58	28	65	-15
Profit Before Tax & Extraordinary Items	36	44	73	114	127	83	134	220	156	252
Depreciation	16	15	15	19	20	17	16	15	40	29
Interest (Net)	-6	-9	-11	-11	-8	-11	-22	-31	-30	-19
Profit / Loss on Sale of Assets	0	-6	0	0	-2	-3	-2	0	0	0
Provisions & Write-offs (Net)	4	3	3	2	3	4	2	7	62	24
Profit / Loss in Forex	0	0	0	0	0	0	0	0	-1	-1
Receivables	38	-12	-28	-5	-5	-5	-23	-51	-32	-46
Inventories	19	-55	-5	-47	5	20	-50	-38	-321	-479
Trade Payables	-45	40	41	41	-31	12	37	-31	260	326
Loans & Advances	2	1	0	-1	0	0	0	1	0	0
Direct Taxes Paid	-12	-4	-35	-34	-33	-25	-41	-56	-64	-83
+ Cash from Investing Activity	0	-9	4	-171	173	5	18	22	31	19
Purchase of Fixed Assets	-6	-6	-19	-14	-8	-10	-9	-11	-2	-4
Sale of Fixed Assets	0	0	0	0	2	3	3	0	1	0
Sale of Investments	0	0	0	0	0	0	0	0	0	0
Interest Received	6	8	11	12	9	11	23	32	32	22
Others	0	-11	12	-169	169	0	0	0	0	0
+ Cash from Financing Activity	0	0	0	-6	-9	-9	-24	-44	-66	-92
Repayment of Financial Liabilities	0	0	0	-2	-3	-4	-4	-4	-4	-7
Dividend Paid	0	0	0	-3	-5	-5	-20	-40	-60	-80
Others	0	0	0	-1	0	0	0	0	0	0
Net Cash Flow	38	-1	59	-90	269	96	52	5	31	-88